Tech Center 1600 • Art Units: 1671 1672
This examiner grants 29% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17925920 | CORONAVIRUS ANTIGEN COMPOSITIONS AND THEIR USES | Final Rejection | Flagship Pioneering Innovations VI, LLC |
| 18022050 | COMPOSITION FOR DIAGNOSING INFECTIOUS DISEASES COMPRISING AGENT FOR MEASURING EXPRESSION LEVEL OF SREBP2 | Final Rejection | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
| 17631439 | TARGETED EXOSOME BASED ON RBD REGION OF SARS-COV-2 S PROTEIN AND PREPARATION METHOD THEREOF | Non-Final OA | SOOCHOW UNIVERSITY |
| 17594349 | A METHOD OF IDENTIFYING A FLAVIVIRUS INFECTION, AND RELATED PEPTIDES, KITS AND COMPOSITIONS | Non-Final OA | Agency for Science, Technology and Research |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy